1,392
Views
13
CrossRef citations to date
0
Altmetric
Short Communication

Morning stiffness response with delayed-release prednisone after ineffective course of immediate-release prednisone

, , , , , & show all
Pages 354-358 | Accepted 03 Apr 2015, Published online: 26 Jun 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Vibeke Strand, Ruchitbhai Shah, Chris Atzinger, Jifang Zhou, Jerry Clewell, Arijit Ganguli & Namita Tundia. (2020) Economic burden of fatigue or morning stiffness among patients with rheumatoid arthritis: a retrospective analysis from real-world data. Current Medical Research and Opinion 36:1, pages 161-168.
Read now
Cindy Strehl, Marlies C. van der Goes, Johannes W.J. Bijlsma, Johannes W. G. Jacobs & Frank Buttgereit. (2017) Glucocorticoid-targeted therapies for the treatment of rheumatoid arthritis. Expert Opinion on Investigational Drugs 26:2, pages 187-195.
Read now
Stefano Paolo Beltrametti, Aurora Ianniello & Clara Ricci. (2016) Chronotherapy with low-dose modified-release prednisone for the management of rheumatoid arthritis: a review. Therapeutics and Clinical Risk Management 12, pages 1763-1776.
Read now
Marco Krasselt & Christoph Baerwald. (2016) Efficacy and safety of modified-release prednisone in patients with rheumatoid arthritis. Drug Design, Development and Therapy 10, pages 1047-1058.
Read now
Hideto To. (2016) Chronotherapy for rheumatoid arthritis: current perspectives. ChronoPhysiology and Therapy 6, pages 47-53.
Read now

Articles from other publishers (8)

Kathryn J. Gray & Julie E. Gibbs. (2022) Adaptive immunity, chronic inflammation and the clock. Seminars in Immunopathology 44:2, pages 209-224.
Crossref
Kristy Bell, Claire Dykas, Bridget Muckian, Brooke Williams, Hope Rainey, Maggy Comberg, Mary Mora, Katherine A. Owen & Peter E. Lipsky. (2021) Patient‐Reported Outcome Information Collected from Lupus Patients Using a Mobile Application: Compliance and Validation . ACR Open Rheumatology 4:2, pages 99-109.
Crossref
Frank Buttgereit. (2020) Views on glucocorticoid therapy in rheumatology: the age of convergence. Nature Reviews Rheumatology 16:4, pages 239-246.
Crossref
Shigehiro Ohdo, Satoru Koyanagi & Naoya Matsunaga. (2019) Chronopharmacological strategies focused on chrono-drug discovery. Pharmacology & Therapeutics 202, pages 72-90.
Crossref
William J. Warrender, Harold I. Salmons, Peter Pham, Cynthia Watkins, Christopher Jones & Michael Rivlin. (2019) Physiological Nocturnal Hand Swelling: A Prospective Evaluation of Healthy Volunteers. The Journal of Hand Surgery 44:3, pages 245.e1-245.e5.
Crossref
S. Jayashree, K. Nirekshana, Gunjan Guha & Dipita Bhakta-Guha. (2018) Cancer chemotherapeutics in rheumatoid arthritis: A convoluted connection. Biomedicine & Pharmacotherapy 102, pages 894-911.
Crossref
Ara H. Dikranian, Rubaiya Mallay, Mike Marshall, Megan Francis-Sedlak & Robert J. Holt. (2017) Switching From Immediate-Release to Delayed-Release Prednisone in Moderate to Severe Rheumatoid Arthritis: A Practice-Based Clinical Study. Rheumatology and Therapy 4:2, pages 363-374.
Crossref
Andrea Cerciello, Giulia Auriemma, Silvana Morello, Rita P. Aquino, Pasquale Del Gaudio & Paola Russo. (2016) Prednisolone Delivery Platforms: Capsules and Beads Combination for a Right Timing Therapy. PLOS ONE 11:7, pages e0160266.
Crossref